π Medicine Name:
Arsenic Trioxide
π Formulation:
Injection, Intravenous (IV) use
πͺ Strength:
1 mg/mL
(typically available in a 10 mL vial = total 10 mg per vial)
π Description:
Arsenic trioxide is a cytotoxic agent used mainly in the treatment of Acute Promyelocytic Leukemia (APL). It induces apoptosis and partial differentiation of malignant promyelocytes, especially in patients with the t(15;17) translocation involving the PML-RARΞ± fusion gene.
π§Ύ Prescription:
Prescription-only medicine (Rx)
Administered only under specialist supervision (typically hematologist/oncologist).
βοΈ Mechanism of Action:
- Promotes apoptosis of leukemia cells.
- Causes degradation of the PML-RARΞ± fusion protein, correcting the abnormal block in differentiation.
- Has pro-differentiation and cytotoxic effects depending on dose.
π― Indications / Uses:
Primarily used for:
- Acute Promyelocytic Leukemia (APL):
- Newly diagnosed, low- to intermediate-risk APL (in combination with ATRA).
- Relapsed or refractory APL, especially after failure of retinoids and anthracyclines.
π¦ Common Packaging:
- 10 mL vial containing 1 mg/mL of arsenic trioxide.
- Single-dose vial.
- Labeled as a cytotoxic drug β handle with gloves and proper precautions.
π Dosage & Administration:
- Administered intravenously (IV) over 1β2 hours.
- Typical initial dose (induction phase):
0.15 mg/kg/day until remission (up to 60 doses). - Followed by consolidation cycles (e.g., 25 doses over 5 weeks).
- Diluted in 100β250 mL of 5% dextrose or saline before administration.
- Central line recommended to minimize vein irritation.
π§ Storage:
- Store at 15β30Β°C (room temperature).
- Protect from light and freezing.
- Use immediately after opening β single-use vial.
β οΈ Precautions:
- QT prolongation β Risk of life-threatening arrhythmias (Torsades de Pointes):
- Monitor ECG, potassium, magnesium levels.
- Monitor liver function, renal function, electrolytes, and blood counts.
- Risk of differentiation syndrome:
- Fever, weight gain, respiratory distress, pulmonary infiltrates, effusions.
- Treated with dexamethasone.
π¨ββοΈ Patient Advice:
- You will need regular blood tests and heart monitoring (ECG).
- Report:
- Chest pain, palpitations, or shortness of breath
- Swelling, sudden weight gain, or difficulty breathing
- Avoid other drugs that prolong the QT interval.
- Maintain adequate hydration.
- Female patients must avoid pregnancy; use effective contraception.

